Showing 1,861 - 1,880 results of 3,189 for search '"vaccines"', query time: 0.06s Refine Results
  1. 1861
  2. 1862

    Impact of COVID-19 on routine childhood immunisations in low- and middle-income countries: A scoping review. by Milena Dalton, Benjamin Sanderson, Leanne J Robinson, Caroline S E Homer, William Pomat, Margie Danchin, Stefanie Vaccher

    Published 2023-01-01
    “…Routine vaccines are critical to child health. The COVID-19 pandemic significantly impacted essential health services, particularly in low-and middle-income countries (LMICs). …”
    Get full text
    Article
  3. 1863

    The Informed Consent in Allergology from a Scientific, Technological and Social Perspective by Marisela Luisa Pérez Pacaréu, Yanet Morejón del Rosario, Gloria Arlenys Suárez Rodríguez, Aleima Rodríguez Carbajal

    Published 2015-11-01
    “…This paper reviews the application of the informed consent within the specialty of allergology in procedures (skin tests), therapeutic interventions (immunotherapy) and research (clinical trials) from a scientific, technological and social perspective, based on the advances achieved in Cuba in recent years to obtain better allergenic extracts for testing, high-quality vaccines and new drugs to benefit the allergic patient. …”
    Get full text
    Article
  4. 1864

    Megapneumonia Coinfection: pneumococcus, Mycoplasma pneumoniae, and Metapneumovirus by Kam Lun Hon, Margaret Ip, Winnie Chiu Wing Chu, William Wong

    Published 2012-01-01
    “…We report a young girl who died of Streptococcus pneumoniae 19A pneumonia, septic shock, and hemolytic uremic syndrome despite prior pneumococcal vaccination, appropriate antibiotics, and aggressive intensive care support. …”
    Get full text
    Article
  5. 1865

    Design and Performance of Solar PV Integrated Domestic Vapor Absorption Refrigeration System by Divya Arputham Selvaraj, Kirubakaran Victor

    Published 2021-01-01
    “…They can also help lifesaving vaccines to reach even the isolated parts of the world. …”
    Get full text
    Article
  6. 1866

    AAV-based vectors for human diseases modeling in laboratory animals by Timur I. Aliev, Dmitry V. Yudkin

    Published 2025-02-01
    “…The development of therapeutic drugs and vaccines requires the availability of appropriate model animals that replicate the pathogenesis of human diseases. …”
    Get full text
    Article
  7. 1867

    Strategies to Overcome Antileishmanial Drugs Unresponsiveness by Shyam Sundar, Anup Singh, Om Prakash Singh

    Published 2014-01-01
    “…In the absence of effective vector control measures and vaccines against leishmaniasis, effective chemotherapy remains the mainstay of treatment. …”
    Get full text
    Article
  8. 1868
  9. 1869

    Algorithms for Processing Coronavirus Genomes for the Goals and Objectives of Modern Immunoinformatics, Vaccinomics, and Virology by M. V. Sprindzuk, A. S. Vladyko, L. P. Titov, Lu Zhuozhuang, V. I. Bernik

    Published 2022-06-01
    “…However, for the complete analysis and implementation of, for example, the epitope vaccines, subsequent validation by the laboratory and in vivo experiments are required.…”
    Get full text
    Article
  10. 1870

    Aging Adults and Seasonal Influenza: Does the Vitamin D Status (H)Arm the Body? by Pierre Olivier Lang, Dimitrios Samaras

    Published 2012-01-01
    “…Evidence that VitD affects clearance of selected pathogens is supported by epidemiological and clinical data, while its coadministration with influenza vaccine in mice enhanced both mucosal and systemic antibody responses. …”
    Get full text
    Article
  11. 1871

    Mucosal Herpes Immunity and Immunopathology to Ocular and Genital Herpes Simplex Virus Infections by Aziz Alami Chentoufi, Lbachir BenMohamed

    Published 2012-01-01
    “…The progress and limitations in developing a safe and efficient mucosal herpes vaccine are discussed.…”
    Get full text
    Article
  12. 1872

    New Immunotherapeutic Approaches for Glioblastoma by Gustavo Ignacio Vázquez Cervantes, Dinora F. González Esquivel, Saúl Gómez-Manzo, Benjamín Pineda, Verónica Pérez de la Cruz

    Published 2021-01-01
    “…The immunotherapies for GMB including monoclonal antibodies, checkpoint inhibitors, vaccines, and oncolytic viruses, among others, have shown favorable results alone or as a multimodal treatment. …”
    Get full text
    Article
  13. 1873

    Anti-HSV-1 agents: an update by Wenwen Lv, Lei Zhou, Jia Wu, Jishuai Cheng, Yongzhong Duan, Wen Qian

    Published 2025-01-01
    “…To date, there are no approved commercially available vaccines, and anti-HSV-1 drugs such as specific or non-specific nucleotide (nucleoside) analogs and helicase-primase inhibitors have become the main clinical agents for the treatment of HSV-1 infections despite challenges from resistance. …”
    Get full text
    Article
  14. 1874

    Current strategies in diagnostics and therapeutics against novel coronavirus disease (COVID-19) by ALOTAIBI FAISAL

    Published 2022-06-01
    “…However, in several areas of the world, vaccination initiatives took place; the vaccines’ safety and efficacy to control the outbreak is yet to be identified. …”
    Get full text
    Article
  15. 1875

    Immunogenetic Factors Associated with Severe Respiratory Illness Caused by Zoonotic H1N1 and H5N1 Influenza Viruses by Jennifer Juno, Keith R. Fowke, Yoav Keynan

    Published 2012-01-01
    “…By better defining the role of genetic variability in influenza infection and identifying key polymorphisms that impair the host immune response or correlate with protection, we will be able to better identify at-risk populations and new targets for therapeutic interventions and vaccines. This paper will summarize known immunogenetic factors associated with susceptibility or severity of both pH1N1 and H5N1 infections and will also identify genetic pathways and polymorphisms of high relevance for future study.…”
    Get full text
    Article
  16. 1876

    Fundamentals and Methods for T- and B-Cell Epitope Prediction by Jose L. Sanchez-Trincado, Marta Gomez-Perosanz, Pedro A. Reche

    Published 2017-01-01
    “…There is great interest in identifying epitopes in antigens for a number of practical reasons, including understanding disease etiology, immune monitoring, developing diagnosis assays, and designing epitope-based vaccines. Epitope identification is costly and time-consuming as it requires experimental screening of large arrays of potential epitope candidates. …”
    Get full text
    Article
  17. 1877

    Decision Support System Based on CoCoSo Method with the Picture Fuzzy Information by Muhammad Qiyas, Muhammad Naeem, Saifullah Khan, Saleem Abdullah, Thongchi Botmart, Tajammul Shah

    Published 2022-01-01
    “…The number of instances of this disease is increasing at an exponential, but there are now commercially accessible COVID-19 vaccines. The weak symptoms of COVID-19 disease, on the other hand, are treated with a variety of antiviral treatments. …”
    Get full text
    Article
  18. 1878

    Tumour Immunotherapy and Applications of Immunological Products: A Review of Literature by Angus Nnamdi Oli, Samson Adedeji Adejumo, Adekunle Babajide Rowaiye, Joyce Oloaigbe Ogidigo, Jarrad Hampton-Marcell, Gordon C. Ibeanu

    Published 2024-01-01
    “…We critically evaluate the current immunotherapy approaches, including cancer vaccines, adoptive T cell therapies, and cytokine-based treatments, highlighting their efficacy and safety. …”
    Get full text
    Article
  19. 1879

    Long-Term Survival and PSA Control with Radiation and Immunotherapy for Node Positive Prostate Cancer by M. Kamrava, Kwong Y. Tsang, R. A. Madan, A. Kaushal, C. N. Coleman, J. Gulley

    Published 2009-01-01
    “…Further evaluation of therapeutic cancer vaccines in combination with radiation and hormonal therapy in the definitive management of prostate cancer is warranted.…”
    Get full text
    Article
  20. 1880

    Heat stable and intrinsically sterile liquid protein formulations by Atip Lawanprasert, Harminder Singh, Sopida Pimcharoen, Mariangely González Vargas, Arshiya Dewan, Girish S. Kirimanjeswara, Scott H. Medina

    Published 2024-12-01
    “…Abstract Over 80% of biologic drugs, and 90% of vaccines, require temperature-controlled conditions throughout the supply chain to minimize thermal inactivation and contamination. …”
    Get full text
    Article